EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany

Constantin Rieger, Jörg Schlüchtermann, Julian Heidenreich, Olivia Steenbock, Florian A Schmid, Richard Weiten, Christian Bach, David Pfister, Axel Heidenreich

European Journal of Cancer · 2025-09 · 227 · 115621

DOI: 10.1016/j.ejca.2025.115621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025-09. Verfasst von Constantin Rieger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany. Electronic addres…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsAntibodies, MonoclonalHumansCost-Benefit AnalysisGermanyCisplatinDeoxycytidineGemcitabineQuality-Adjusted Life YearsMarkov ChainsNeoplasm InvasivenessModels, EconomicMaleMonte Carlo MethodFemaleDrug CostsCost-Effectiveness Analysis

Stichwörter der Autor:innen

Bladder cancerCost-effectiveDurvalumabEconomic analysisNeoadjuvant treatment

Substanzen

durvalumabAntibodies, MonoclonalCisplatinDeoxycytidineGemcitabine

Autor:innen und Institutionen

  • Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany. Electronic address: constantin.rieger@uk-koeln.de.
  • Faculty of Law, Business and Economics, University of Bayreuth, Bayreuth, Germany.
  • Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.
  • Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany; Department of Urology, University Hospital of Zurich, Zurich, Switzerland.
  • Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany; Department of Urology, Medical University Vienna, Austria.

Zitieren

APA

Rieger, C., Schlüchtermann, J., Heidenreich, J., Steenbock, O., Schmid, F. A., Weiten, R., Bach, C., Pfister, D., & Heidenreich, A. (2025). Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany. European Journal of Cancer, 227, 115621. https://doi.org/10.1016/j.ejca.2025.115621

Vancouver

Rieger C, Schlüchtermann J, Heidenreich J, Steenbock O, Schmid FA, Weiten R, et al. Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany. European Journal of Cancer. 2025;227:115621. doi:10.1016/j.ejca.2025.115621

BibTeX
@article{Rieger2025,
  author = {Rieger, Constantin and Schlüchtermann, Jörg and Heidenreich, Julian and Steenbock, Olivia and Schmid, Florian A and Weiten, Richard and Bach, Christian and Pfister, David and Heidenreich, Axel},
  title = {Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {227},
  pages = {115621},
  doi = {10.1016/j.ejca.2025.115621}
}
Kostenlos starten →